BPI
AZR icon

BFC Planning, Inc.’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

BFC Planning, Inc.’s Portfolio AZR Stock Details AZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$6 – 3041
2025
Q4 		$6 Hold
1
– – ﹤0.01% 3212
2025
Q3 		$10 Buy
+1
New +$10 ﹤0.01% 2883
2025
Q2 		– Sell
-1
Closed -$18 – 2662
2025
Q1 		$18 Hold
1
– – ﹤0.01% 2648
2024
Q4 		$28 Hold
1
– – ﹤0.01% 2576
2024
Q3 		$28 Buy
+1
New +$26 ﹤0.01% 2573

Other funds holding AZR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Manchester Capital Management
Manchester Capital Management Manchester, Vermont $736M AUM 20.83% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Raffa Wealth Management
Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

BFC Planning, Inc.'s AZR Position: Q1 2026 in Review

BFC Planning, Inc. sold out of Azora Therapeutics, Inc. Common Stock (AZR) in Q1 2026, closing a stake of 1 share — an estimated $6 sold.

BFC Planning, Inc. first reported a position in AZR in Q3 2024 and held it in 5 quarters. The position peaked at $28 in Q4 2024. 15 funds tracked by Wall St. Rank hold AZR as of Q1 2026.

  • BFC Planning, Inc. reported no remaining Azora Therapeutics, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • BFC Planning, Inc. sold 1 Azora Therapeutics, Inc. Common Stock share in Q1 2026, an estimated $6.
  • BFC Planning, Inc. first reported a position in Azora Therapeutics, Inc. Common Stock in Q3 2024 and held it in 5 quarters.
  • BFC Planning, Inc.'s Azora Therapeutics, Inc. Common Stock position peaked at $28 in Q4 2024.
  • 15 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q1 2026.

Based on BFC Planning, Inc.'s 13F filing for Q1 2026, filed 29 Oct 2026.